About the Lovell lab
The lab was born in the State University of New York at Buffalo's new Biomedical Engineering program in 2012. Broadly, our focus is on developing novel nanomedicine approaches to meet unmet needs in treating and diagnosing disease. We strive to use good engineering principles to iteratively design, synthesize, characterize, test and validate next generation nanoparticles and biosensors with the ultimate goal of making a translational impact on improving human health. Developing safer, organic nanoparticles that will allow superior treatment options for cancer therapy is a major research thrust.